> ProgramProgram
Sicentific Program(Day 1/Day 2)
연수평점 : 최대 8점(2일간)
| Time | Program | Speaker |
|---|---|---|
| 08:30-09:00 | Registration | |
| 09:00-10:30 | KPS-APSU Meeting | |
| 10:30-10:50 | Coffee Break | |
| 10:50-12:00 | Poster Session | |
| 12:00-13:00 | Lunch | |
| 13:00-13:20 | Opening Ceremony | Jun Hyuk HONG (President of KPS) Ji Youl LEE (President of APSU) |
| 13:20-14:30 | Session I: Kidney Cancer I | Seong Il SEO (Korea), Lukman HAKIM (Indonesia) |
| 15 | Active surveillance and ablative therapies : When and how | Taekmin KWON (KOREA) |
| 20 | Single port prostatectomy: Simple, retropubic and retzius sparing, The Mayo Clinic Experience | Matthew K. TOLLEFSON (USA) |
| 20 | The evolving role of cytoreductive nephrectomy after Carmena | Surena F. MATIN (USA) |
| 15 | Panel Discussion : JinKyu OH(Korea), Edmund CHIONG (Singapore), Norio NOMOMURA (Japan), Todd M. MORGAN (USA), Gyeong Eun MIN (Korean), Bum Sik TAE(Korea) | |
| 14:30-15:35 | Session II: Bladder Cancer I | Tag Keun YOO (Korea) Bannakij LOJANAPIWAT (Thailand) |
| 15 | Beyond BCG in non-muscle invasive bladder cancer | Hyung Suk KIM (Korea) |
| 15 | Update of lymph node dissection during radical cystectomy | Wan SONG (Korea) |
| 20 | Comparative Efficacy of Robotic Assisted Radical Cystectomy | Michael S. COOKSON (USA) |
| 15 | Panel Discussion : Jun Hyun HAN (Korea), Jin Seon CHO (Korea), Byung Hoon KIM(Korea), In-Chang CHO (Korea), Seol Ho CHOO (Korea), Seung Chol PARK (Korea), Jung Sik HUH (Korea) | |
| 15:35-15:50 | Coffee Break | |
| 15:50-17:00 | Session III: Prostate Cancer I | Ji Youl LEE (Korea) Rainy UMBAS (Indonesia) |
| 15 | The role of MRI before prostate biopsy | Myungsun SHIM (Korea) |
| 20 | PSMA PET is changing the landscape of prostate cancer | Timothy F. DONAHUE (USA) |
| 20 | The implications of germline testing in localized prostate cancer | Todd M. MORGAN (USA) |
| 10 | Panel Discussion :Taek Won KANG (Korea), Edmund CHIONG (Singapore), Teng Aik ONG (Malaysia), Hong Seok PARK (Korea), Young Eun YOON (Korea), Young Hwii KO (Korea) | |
| 17:00- | Welcome Dinner | |
| Time | Program | Speaker |
|---|---|---|
| 08:30-08:50 | Registration | |
| 08:50-09:00 | Welcome Message | Kyu-Sung LEE (President of KUA) |
| 09:00-10:00 | Session IV: Potpourri: Issues to Consider | Kyung Seop LEE (Korea) Edmund CHIONG (Singapore) |
| 15 | Efficacy and Safety of Tamsulosin 0.4mg in Patients with LUTS/BPH | Se Yun KWON (Korea) |
| 15 | GnRH agonist in prostate cancer | Se Young CHOI (Korea) |
| 15 | Optimal management of male LUTS/BPH – Combination therapy of tamsulosin & dutasteride | Byung Ha CHUNG (Korea) |
| 15 | Panel Discussion : Jeong Seok HWA (Korea), Seung-Ju LEE (Korea), Tae Young JUNG (Korea), Jae Young PARK (Korea), Phil Hyun SONG (Korea), Lukman HAKIM (Indonesia) | |
| 10:00-10:20 | Coffee Break | |
| 10:20-11:50 | Session V: Prostate Cancer II | Norio NONOMURA (Japan) Hyun Moo LEE (Korea) |
| 20 | Focal therapy is not yet ready for prime time | Timothy F. DONAHUE (USA) |
| 20 | Single port prostatectomy: Simple, retropubic and retzius sparing, The Mayo Clinic Experience | Matthew K. TOLLEFSON USA) |
| 15 | Artificial urinary sphincter for the management of post-prostatectomy incontinence | Kwang Jin KO (Korea) |
| 15 | Treatment of Patients with Biochemical Recurrence after Radical Prostatectomy | Hakmin LEE (Korea) |
| 20 | Panel Discussion : Kyung Hyun MOON (Korea), Hwang Gyun JEON (Korea), Seung Hwan LEE (Korea), Bannakij LOJANAPIWAT (Thailand), Surena F. MATIN (USA), Sun Il KIM (Korea), Seong Soo JEON (Korea) | |
| 11:50-12:50 | Lunch | |
| 12:50-14:15 | Session VI: Prostate Cancer III | Byung Ha CHUNG (Korea) Teng Aik ONG (Malaysia) |
| 20 | Management of Metastatic and Castration Resistant CRPC: What’s New? | Michael S. COOKSON (USA) |
| 15 | Application of intensive treatment of positive pelvic lymph nodes | Kwang Hyun KIM (KOREA) |
| 15 | Local treatment in de novo metastatic prostate cancer | Won Sik JANG (Korea) |
| 20 | Prostate Cancer Genomics: Where Are We & Where Are We Going? | Todd M. MORGAN (USA) |
| 15 | Panel Discussion : Sung Kyu HONG (Korea), Yun Beom KIM (Korea), Lukman HAKIM (Indonesia), Norio NOMOMURA (Japan), Michael S. COOKSON (USA), Junghyun KIM (Korea), Sang Hyeon CHEON (Korea) | |
| 14:15-14:40 | Coffee Break | |
| 14:40-15:45 | Session VII: Upper Tract Urothelial Cancer | Jae IL CHUNG (Korea) Chun Il KIM (Korea) |
| 15 | Nephron-sparing surgery of upper tract urothelial cancer | Sung Yong CHO (Korea) |
| 15 | Perioperative chemotherapy for upper tract urothelial cancer | Jong Chan KIM (Korea) |
| 20 | Clinical updates and translational correlates | Surena F. MATIN (USA) |
| 15 | Panel Discussion : Jun Sung KOH (Korea), Moon Ki JO(Korea), Jae Heon KIM (Korea), Jae-Seung CHUNG (Korea), Ho Kyung SEO (Korea) | |
| 15:45-17:00 | Session VIII: Prostate Cancer IV | Sang Eun LEE (Korea) Jun Hyuk HONG (Korea) |
| 15 | Tailoring therapy in metastatic hormone-sensitive prostate cancer | Wook NAM (Korea) |
| 15 | M0CRPC : is imaging good enough? | Won Ik SEO (Korea) |
| 15 | AR-targeting therapy in non-metastatic (M0) castration resistant prostate cancer | Jongwook PARK (Korea) |
| 15 | Bone-targeting therapy in metastatic prostate cancer | Sung Han KIM (Korea) |
| 15 | Panel Discussion : Sung-Woo PARK (Korea), U-Syn HA (Korea), Bannakij LOJANAPIWAT (Thailand), Young-Sig KIM (Korea), Jae Young JOUNG (Korea), Kyo Chul KOO (Korea) | |
| 17:00 | Closing Remarks | Jun Hyuk HONG (President of KPS) Ji Youl LEE (President of APSU) |